Cargando…

Tetanus, Diphtheria, and Acellular Pertussis Vaccination Coverage Among Publicly Insured Pregnant Women, U.S., 2016–2019

INTRODUCTION: Vaccination with tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine during pregnancy is highly effective against Bordetella pertussis in young infants. We aimed to evaluate the uptake of maternal tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis...

Descripción completa

Detalles Bibliográficos
Autores principales: Isenhour, Cheryl J., Skoff, Tami H., Lindley, Megan C., Zhou, Fangjun, Hariri, Susan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10546573/
https://www.ncbi.nlm.nih.gov/pubmed/37789941
http://dx.doi.org/10.1016/j.focus.2022.100060
_version_ 1785114885801115648
author Isenhour, Cheryl J.
Skoff, Tami H.
Lindley, Megan C.
Zhou, Fangjun
Hariri, Susan
author_facet Isenhour, Cheryl J.
Skoff, Tami H.
Lindley, Megan C.
Zhou, Fangjun
Hariri, Susan
author_sort Isenhour, Cheryl J.
collection PubMed
description INTRODUCTION: Vaccination with tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine during pregnancy is highly effective against Bordetella pertussis in young infants. We aimed to evaluate the uptake of maternal tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccination during the recommended gestation period of 27 through 36 weeks among women enrolled in a public medical insurance plan in the U.S. METHODS: In this analysis using Centers for Medicare and Medicaid Services insurance claims data, we identified women aged 15 through 49 years who delivered a live-born infant from 2016 through 2019. We identified claims for tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccination to calculate the proportion of women who were vaccinated during Weeks 27 through 36 of gestation in each calendar year. We also assessed the average annual maternal tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis coverage by age group, race and ethnicity, U.S. Census region of residence, and plan type. Data were analyzed in 2021. RESULTS: Among 4,318,823 deliveries, the 4-year national average for tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccination was 26%, improving from 22% in 2016 to 31% in 2019 (p<0.001). Within subgroups, the lowest 4-year average coverage was among women aged 15 through 18 years (22%); Black, non-Hispanic (23%) and Hispanic women (24%); those residing in the South (18%); those enrolled in a Children's Health Insurance Program plan (22%); and those covered by a fee-for-service plan (19%). Coverage increased across all subgroups from 2016 through 2019. CONCLUSIONS: Although maternal tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis coverage among publicly insured women in the U.S. increased from 2016 through 2019, it remained considerably lower than estimated national coverage, with notable differences by race and ethnicity.
format Online
Article
Text
id pubmed-10546573
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-105465732023-10-03 Tetanus, Diphtheria, and Acellular Pertussis Vaccination Coverage Among Publicly Insured Pregnant Women, U.S., 2016–2019 Isenhour, Cheryl J. Skoff, Tami H. Lindley, Megan C. Zhou, Fangjun Hariri, Susan AJPM Focus Research Article INTRODUCTION: Vaccination with tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine during pregnancy is highly effective against Bordetella pertussis in young infants. We aimed to evaluate the uptake of maternal tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccination during the recommended gestation period of 27 through 36 weeks among women enrolled in a public medical insurance plan in the U.S. METHODS: In this analysis using Centers for Medicare and Medicaid Services insurance claims data, we identified women aged 15 through 49 years who delivered a live-born infant from 2016 through 2019. We identified claims for tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccination to calculate the proportion of women who were vaccinated during Weeks 27 through 36 of gestation in each calendar year. We also assessed the average annual maternal tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis coverage by age group, race and ethnicity, U.S. Census region of residence, and plan type. Data were analyzed in 2021. RESULTS: Among 4,318,823 deliveries, the 4-year national average for tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccination was 26%, improving from 22% in 2016 to 31% in 2019 (p<0.001). Within subgroups, the lowest 4-year average coverage was among women aged 15 through 18 years (22%); Black, non-Hispanic (23%) and Hispanic women (24%); those residing in the South (18%); those enrolled in a Children's Health Insurance Program plan (22%); and those covered by a fee-for-service plan (19%). Coverage increased across all subgroups from 2016 through 2019. CONCLUSIONS: Although maternal tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis coverage among publicly insured women in the U.S. increased from 2016 through 2019, it remained considerably lower than estimated national coverage, with notable differences by race and ethnicity. Elsevier 2022-12-22 /pmc/articles/PMC10546573/ /pubmed/37789941 http://dx.doi.org/10.1016/j.focus.2022.100060 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Article
Isenhour, Cheryl J.
Skoff, Tami H.
Lindley, Megan C.
Zhou, Fangjun
Hariri, Susan
Tetanus, Diphtheria, and Acellular Pertussis Vaccination Coverage Among Publicly Insured Pregnant Women, U.S., 2016–2019
title Tetanus, Diphtheria, and Acellular Pertussis Vaccination Coverage Among Publicly Insured Pregnant Women, U.S., 2016–2019
title_full Tetanus, Diphtheria, and Acellular Pertussis Vaccination Coverage Among Publicly Insured Pregnant Women, U.S., 2016–2019
title_fullStr Tetanus, Diphtheria, and Acellular Pertussis Vaccination Coverage Among Publicly Insured Pregnant Women, U.S., 2016–2019
title_full_unstemmed Tetanus, Diphtheria, and Acellular Pertussis Vaccination Coverage Among Publicly Insured Pregnant Women, U.S., 2016–2019
title_short Tetanus, Diphtheria, and Acellular Pertussis Vaccination Coverage Among Publicly Insured Pregnant Women, U.S., 2016–2019
title_sort tetanus, diphtheria, and acellular pertussis vaccination coverage among publicly insured pregnant women, u.s., 2016–2019
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10546573/
https://www.ncbi.nlm.nih.gov/pubmed/37789941
http://dx.doi.org/10.1016/j.focus.2022.100060
work_keys_str_mv AT isenhourcherylj tetanusdiphtheriaandacellularpertussisvaccinationcoverageamongpubliclyinsuredpregnantwomenus20162019
AT skofftamih tetanusdiphtheriaandacellularpertussisvaccinationcoverageamongpubliclyinsuredpregnantwomenus20162019
AT lindleymeganc tetanusdiphtheriaandacellularpertussisvaccinationcoverageamongpubliclyinsuredpregnantwomenus20162019
AT zhoufangjun tetanusdiphtheriaandacellularpertussisvaccinationcoverageamongpubliclyinsuredpregnantwomenus20162019
AT haririsusan tetanusdiphtheriaandacellularpertussisvaccinationcoverageamongpubliclyinsuredpregnantwomenus20162019